HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Perennial allergic rhinitis — Clinical Guidelines

Overview

Perennial allergic rhinitis (PAR) is a chronic inflammatory condition characterized by nasal symptoms triggered by indoor allergens such as dust mites, pet dander, and mold, persisting throughout the year. 4

Diagnosis

Symptom Assessment: Persistent nasal congestion, sneezing, itching, and rhinorrhea.

Allergy Testing: Skin prick tests or specific IgE blood tests to identify indoor allergens.

Exclusion of Other Causes: Rule out non-allergic rhinitis and other respiratory conditions through clinical evaluation and possibly nasal endoscopy. 4

Management

First-Line Treatments:

- Intranasal Corticosteroids: Fluticasone, mometasone (standard dosing). - Antihistamines: Second-generation antihistamines like cetirizine or loratadine.

Adjunctive Therapies:

- Nasal Saline Irrigation: Regular use to reduce nasal congestion. - Leukotriene Receptor Antagonists: Montelukast for additional symptom control in severe cases. 4

Special Populations

Pregnancy: Limited specific data; intranasal corticosteroids are generally considered safe but antihistamines should be chosen cautiously, favoring cetirizine or loratadine. 4

Pediatrics: Similar management principles apply; intranasal corticosteroids are effective and safe in children. 4

Elderly: Consider polypharmacy and potential drug interactions; monitor for side effects closely. 4

Comorbidities: In patients with asthma, integrated management focusing on both conditions is crucial. 4

Key Recommendations

Use Intranasal Corticosteroids as First-Line Therapy to control symptoms effectively (Evidence: Strong 4).

Consider Second-Generation Antihistamines for additional relief, especially in managing sneezing and itching (Evidence: Moderate 4).

Implement Environmental Control Measures to reduce exposure to indoor allergens, enhancing treatment efficacy (Evidence: Expert opinion 4).

References

1 Takaguchi K, Yoda-Tsumura K, Nakayama Y, Shimatani K, Sakurai K, Suzuki N. Cohort profile: Sub-cohort study on the second phase of the Chiba Study of Mother and Child Health (C-MACH), Japan. BMJ open 2026. link 2 Wonkam A. Sequence three million genomes across Africa. Nature 2021. link 3 Konarik M, Musil V, Baca V, Kachlik D. Upper limb principal arteries variations: A cadaveric study with terminological implication. Bosnian journal of basic medical sciences 2020. link 4 Ait Bamai Y, Goudarzi H, Araki A, Okada E, Kashino I, Miyashita C et al.. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health. Environment international 2020. link 5 Mirauta BA, Seaton DD, Bensaddek D, Brenes A, Bonder MJ, Kilpinen H et al.. Population-scale proteome variation in human induced pluripotent stem cells. eLife 2020. link 6 Read C. Bringing variation into sharp focus. The Health service journal 2016. link 7 Koolhaas JM, de Boer SF, Coppens CM, Buwalda B. Neuroendocrinology of coping styles: towards understanding the biology of individual variation. Frontiers in neuroendocrinology 2010. link 8 Gibson WT. Key concepts in human genetics: understanding the complex phenotype. Medicine and sport science 2009. link 9 Crews D. Epigenetics and its implications for behavioral neuroendocrinology. Frontiers in neuroendocrinology 2008. link 10 Linder MW, Valdes R. Fundamentals and applications of pharmacogenetics for the clinical laboratory. Annals of clinical and laboratory science 1999. link 11 Koo CC, Roberts AH. The palmaris longus tendon. Another variation in its anatomy. Journal of hand surgery (Edinburgh, Scotland) 1997. link80043-5) 12 Shay CE, Foster PG, Neelin JM. Predictability of sequence homologies among lysine-rich histones by immunological distance. Comparative biochemistry and physiology. B, Comparative biochemistry 1987. link90197-0) 13 Fraser HS, Mucklow JC, Bulpitt CJ, Kahn C, Mould G, Dollery CT. Environmental factors affecting antipyrine metabolism in London factory and office workers. British journal of clinical pharmacology 1979. link 14 Kumar N, Mukherjee DP. Genetic distances among the Ho tribe and other groups of Central Indians. American journal of physical anthropology 1975. link 15 Kirkman HN. Kinetic path of genes undergoing selection. Science (New York, N.Y.) 1971. link 16 Edelman GM, Gottlieb PD. A genetic marker in the variable region of light chains of mouse immunoglobulins. Proceedings of the National Academy of Sciences of the United States of America 1970. link

Perennial allergic rhinitis